Staar Surgical (STAA) Research & Development (2010 - 2026)

Staar Surgical (STAA) has reported Research & Development for 17 consecutive years, with $26.9 million the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, Research & Development rose 2.51% year-over-year to $26.9 million; the trailing twelve-month figure through Jul 2026 stood at $100.8 million (down 8.86% YoY), and the FY2026 full-year result was $102.5 million, down 12.35% from the prior year.
• Research & Development climbed to $26.9 million in Q3 2026 per STAA's latest filing, from $24.5 million in the prior quarter.
• Across five years, Research & Development topped out at $32.3 million in Q2 2023 and bottomed at $17.3 million in Q2 2022.
• Historically, Research & Development has averaged $26.1 million across 5 years, with a median of $26.4 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Research & Development jumped 52.6% in 2023, then decreased 18.74% in 2025.
• Over 5 years, Research & Development stood at $24.2 million in 2022, then gained by 9.48% to $26.5 million in 2023, then rose by 7.26% to $28.4 million in 2024, then dropped by 17.52% to $23.5 million in 2025, then climbed by 14.85% to $26.9 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $26.9 million, $24.5 million, and $25.8 million for Q3 2026, Q2 2026, and Q1 2026 respectively.